商品名称 | 适用类别 | 通用名称 | 活性成分 | 产品号 | 上市许可开发者/申请人/持有人 | 上市许可日期 | 许可状态 |
---|---|---|---|---|---|---|---|
Yuvanci | Human | macitentan;tadalafil | Macitentan;tadalafil | EMEA/H/C/005001 | Janssen-Cilag International NV | 2024/09/27 | Authorised |
Fymskina | Human | ustekinumab | ustekinumab | EMEA/H/C/005805 | Formycon AG | 2024/09/25 | Authorised |
Otulfi | Human | ustekinumab | ustekinumab | EMEA/H/C/006544 | Fresenius Kabi Deutschland GmbH | 2024/09/25 | Authorised |
Vevizye | Human | ciclosporin | ciclosporin | EMEA/H/C/006250 | Novaliq GmbH | 2024/09/19 | Authorised |
Ranibizumab Midas | Human | ranibizumab | ranibizumab | EMEA/H/C/006528 | Midas Pharma GmbH | 2024/09/19 | Authorised |
Axitinib Accord | Human | axitinib | axitinib | EMEA/H/C/006206 | Accord Healthcare S.L.U. | 2024/09/19 | Authorised |
Vyloy | Human | Zolbetuximab | Zolbetuximab | EMEA/H/C/005868 | Astellas Pharma Europe B.V. | 2024/09/19 | Authorised |
Anzupgo | Human | Delgocitinib | Delgocitinib | EMEA/H/C/006109 | LEO Pharma A/S | 2024/09/19 | Authorised |
Tuznue | Human | trastuzumab | trastuzumab | EMEA/H/C/006252 | Prestige Biopharma Belgium | 2024/09/19 | Authorised |
Loqtorzi | Human | Toripalimab | Toripalimab | EMEA/H/C/006120 | TMC Pharma (EU) Limited | 2024/09/19 | Authorised |
Kayfanda | Human | odevixibat | Odevixibat sesquihydrate | EMEA/H/C/006462 | Ipsen Pharma | 2024/09/19 | Authorised |
Iqirvo | Human | Elafibranor | Elafibranor | EMEA/H/C/006231 | Ipsen Pharma | 2024/09/19 | Authorised |
Eksunbi | Human | ustekinumab | ustekinumab | EMEA/H/C/006448 | Samsung Bioepis NL B.V. | 2024/09/12 | Authorised |
Akantior | Human | polihexanide | Polihexanide | EMEA/H/C/005858 | SIFI SPA | 2024/08/22 | Authorised |
Eurneffy | Human | epinephrine | epinephrine | EMEA/H/C/006139 | Ars Pharmaceuticals Irl Limited | 2024/08/22 | Authorised |
Enzalutamide Viatris | Human | enzalutamide | enzalutamide | EMEA/H/C/006299 | Viatris Limited | 2024/08/22 | Authorised |
Steqeyma | Human | ustekinumab | ustekinumab | EMEA/H/C/005918 | Celltrion Healthcare Hungary Kft. | 2024/08/22 | Authorised |
Winrevair | Human | Sotatercept | sotatercept | EMEA/H/C/005647 | Merck Sharp & Dohme B.V. | 2024/08/22 | Authorised |
Tauvid | Human | Flortaucipir (18F) | Flortaucipir (18F) | EMEA/H/C/006064 | Eli Lilly Nederland B.V. | 2024/08/22 | Authorised |
Nilotinib Accord | Human | nilotinib | nilotinib | EMEA/H/C/006315 | Accord Healthcare S.L.U. | 2024/08/22 | Authorised |